Cargando…
miR-203 inhibits cell proliferation and ERK pathway in prostate cancer by targeting IRS-1
INTRODUCTION: Prostate cancer (PCa) is one of the most common types of cancer in men. In the course of the development and progression of this disease, abnormal expression of miR-203 is usually accompanied. However, its role in prostate tumorigenesis and the underlying mechanism are poorly understoo...
Autores principales: | Meng, Yang, Hu, Xiaoyan, Li, Shasha, Zeng, Xinyi, Qiu, Lei, Wei, Mingtian, Wang, Ziqing, Han, Junhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590475/ https://www.ncbi.nlm.nih.gov/pubmed/33109107 http://dx.doi.org/10.1186/s12885-020-07472-2 |
Ejemplares similares
-
MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer
por: Xiang, Jun, et al.
Publicado: (2015) -
miR-203 Regulates Cell Proliferation through Its Influence on Hakai Expression
por: Abella, Vanessa, et al.
Publicado: (2012) -
miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2
por: Xu, Mingxi, et al.
Publicado: (2015) -
MiR-203 Interplays with Polycomb Repressive Complexes to Regulate the Proliferation of Neural Stem/Progenitor Cells
por: Liu, Pei-Pei, et al.
Publicado: (2017) -
MiR-34a and miR-203 Inhibit Survivin Expression to Control Cell Proliferation and Survival in Human Osteosarcoma Cells
por: Chen, Xun, et al.
Publicado: (2016)